Immune complexome analysis reveals an autoimmune signature predictive of COVID-19 severity
Marino Moriishi,Takahiro Takazono,Junya Hashizume,Nozomi Aibara,Yuki Jimbayashi Kutsuna,Masaki Okamoto,Toyomitsu Sawai,Teppei Hoshino,Yusuke Mori,Yuichi Fukuda,Yukikazu Awaya,Hirotomo Yamanashi,Yuichiro Furusato,Toyoshi Yanagihara,Hirotaka Miyamoto,Kayoko Sato,Yukinobu Kodama,Shusaku Mizukami,Noriho Sakamoto,Kazuko Yamamoto,Kei Sakamoto,Katsunori Yanagihara,Koichi Izumikawa,Takahiro Maeda,Mikiro Nakashima,Kiyoyasu Fukushima,Hiroshi Mukae,Kaname Ohyama
DOI: https://doi.org/10.1016/j.clinbiochem.2024.110865
IF: 3.625
2024-12-18
Clinical Biochemistry
Abstract:Background The factors contributing to the development of severe coronavirus disease 2019 (COVID-19) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unclear. Although the presence of immune complexes (ICs), formed between antibodies and their antigens, has been linked to COVID-19 severity, their role requires further investigation, and the antigens within these ICs are yet to be characterized. Method Here, a C1q enzyme-liked immunosorbent assay and immune complexome analysis were used to determine IC concentrations and characterize IC antigens, respectively, in the sera of 64 unvaccinated COVID-19 patients with PCR-confirmed SARS-CoV-2 infection, enrolled at seven participating centers in 2020. For the analysis, the patients were split into the severe (n = 35) and non-severe (n = 28) groups on the basis of their COVID-19 symptoms. Results We found that neither serum IC concentration nor IC antigen number was associated with COVID-19 severity. However, we identified six IC antigens, which were significantly enriched in the severe versus non-severe group. These IC antigens were all derived from human proteins, namely haptoglobin, the serum amyloid A-2 protein, the serum amyloid A-1 protein, clusterin, and lipopolysaccharide-binding protein, and complement-factor-H-related protein 3. Meanwhile, we found no association between COVID-19 severity and IC antigens derived from SARS-CoV-2 proteins. Collectively, the six IC antigens predicted COVID-19 severity with a moderate degree of accuracy (area under the receiver operating characteristic curve = 0.90, sensitivity = 94 %, specificity = 79 %). Conclusions The IC antigen signature identified in this study may have important implications for the diagnosis and treatment of severe COVID-19.
medical laboratory technology